Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A

NCT01610414 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01610414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01610414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
July 13, 2012
Completion date
February 1, 2017
Enrollment
1,877 (actual)
Sites
178

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster